These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 22959314)

  • 21. Safety of intranasal Bevacizumab (Avastin) treatment in patients with hereditary hemorrhagic telangiectasia-associated epistaxis.
    Chen S; Karnezis T; Davidson TM
    Laryngoscope; 2011 Mar; 121(3):644-6. PubMed ID: 21344447
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of bevacizumab (Avastin) treatment on epistaxis in hereditary hemorrhagic telangiectasia.
    Simonds J; Miller F; Mandel J; Davidson TM
    Laryngoscope; 2009 May; 119(5):988-92. PubMed ID: 19194865
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bevacizumab reverses need for liver transplantation in hereditary hemorrhagic telangiectasia.
    Mitchell A; Adams LA; MacQuillan G; Tibballs J; vanden Driesen R; Delriviere L
    Liver Transpl; 2008 Feb; 14(2):210-3. PubMed ID: 18236396
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The use of anti-fibrinolytic agents in patients with HHT: a retrospective survey.
    Zaffar N; Ravichakaravarthy T; Faughnan ME; Shehata N
    Ann Hematol; 2015 Jan; 94(1):145-52. PubMed ID: 25064693
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bevacizumab: finding its niche in the treatment of heart failure secondary to liver vascular malformations in hereditary hemorrhagic telangiectasia.
    Young LH; Henderson KJ; White RI; Garcia-Tsao G
    Hepatology; 2013 Jul; 58(1):442-5. PubMed ID: 23686865
    [No Abstract]   [Full Text] [Related]  

  • 26. Bevacizumab in hereditary hemorrhagic telangiectasia-associated epistaxis: effectiveness of an injection protocol based on the vascular anatomy of the nose.
    Dheyauldeen S; Østertun Geirdal A; Osnes T; Vartdal LS; Dollner R
    Laryngoscope; 2012 Jun; 122(6):1210-4. PubMed ID: 22565282
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy of intranasal Bevacizumab (Avastin) treatment in patients with hereditary hemorrhagic telangiectasia-associated epistaxis.
    Karnezis TT; Davidson TM
    Laryngoscope; 2011 Mar; 121(3):636-8. PubMed ID: 21344445
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hereditary hemorrhagic telangiectasia/avastin.
    Davidson TM; Olitsky SE; Wei JL
    Laryngoscope; 2010 Feb; 120(2):432-5. PubMed ID: 19998344
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hereditary haemorrhagic telangiectasia with pulmonary arteriovenous malformations: a treatable cause of thromboembolic cerebral events.
    Yoong JK; Htoo MM; Jeyaseelan V; Ng DC
    Singapore Med J; 2004 Jul; 45(7):334-6. PubMed ID: 15221050
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Lung in Hereditary Hemorrhagic Telangiectasia.
    Dupuis-Girod S; Cottin V; Shovlin CL
    Respiration; 2017; 94(4):315-330. PubMed ID: 28850955
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An association of migraine with hereditary haemorrhagic telangiectasia independently of pulmonary right-to-left shunts.
    Marziniak M; Jung A; Guralnik V; Evers S; Prudlo J; Geisthoff UW
    Cephalalgia; 2009 Jan; 29(1):76-81. PubMed ID: 18771488
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Systemic therapy with bevacizumab in patients with hereditary hemorrhagic telangiectasia (HHT).
    Chavan A; Schumann-Binarsch S; Luthe L; Nickau B; Elsässer A; Kühnel T; Geisthoff U; Köhne H
    Vasa; 2013 Mar; 42(2):106-10. PubMed ID: 23485837
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Subcutaneous Tranexamic Acid at the End of Life in a Patient With Hereditary Hemorrhagic Telangiectasia.
    Arndt G; Wai R; Stiel H
    J Palliat Med; 2024 Jun; 27(6):827-829. PubMed ID: 37768837
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatments of Epistaxis in Hereditary Hemorrhagic Telangiectasia: Systematic Review and Network Meta-Analysis.
    Chitsuthipakorn W; Hoang MP; Kanjanawasee D; Seresirikachorn K; Snidvongs K
    Curr Allergy Asthma Rep; 2023 Dec; 23(12):689-701. PubMed ID: 37995018
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Successful therapy with bevacizumab in a case of hereditary hemorrhagic telangiectasia.
    Kochanowski J; Sobieszczańska M; Tubek S; Żurek M; Pawełczak J
    Hum Vaccin Immunother; 2015; 11(3):680-1. PubMed ID: 25839219
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Epistaxis in hereditary haemorrhagic telangiectasia.
    Haitjema T; Balder W; Disch FJ; Westermann CJ
    Rhinology; 1996 Sep; 34(3):176-8. PubMed ID: 8938889
    [TBL] [Abstract][Full Text] [Related]  

  • 37. European Reference Network for Rare Vascular Diseases (VASCERN): When and how to use intravenous bevacizumab in Hereditary Haemorrhagic Telangiectasia (HHT)?
    Dupuis-Girod S; Shovlin CL; Kjeldsen AD; Mager HJ; Sabba C; Droege F; Fargeton AE; Fialla AD; Gandolfi S; Hermann R; Lenato GM; Manfredi G; Post MC; Rennie C; Suppressa P; Sure U; ; Buscarini E
    Eur J Med Genet; 2022 Oct; 65(10):104575. PubMed ID: 35940549
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Efficacy of tranexamic acid in a patient with hereditary hemorrhagic telangiectasia and massive epistaxis].
    Pérez del Molino A; Zarrabeitia R; Fernández A; Botella LM
    Med Clin (Barc); 2004 Jun; 123(3):118-9. PubMed ID: 15225479
    [No Abstract]   [Full Text] [Related]  

  • 39. Treatment of hereditary hemorrhagic telangiectasia with submucosal and topical bevacizumab therapy.
    Karnezis TT; Davidson TM
    Laryngoscope; 2012 Mar; 122(3):495-7. PubMed ID: 22147664
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tranexamic acid for epistaxis in hereditary hemorrhagic telangiectasia patients: a European cross-over controlled trial in a rare disease.
    Gaillard S; Dupuis-Girod S; Boutitie F; Rivière S; Morinière S; Hatron PY; Manfredi G; Kaminsky P; Capitaine AL; Roy P; Gueyffier F; Plauchu H;
    J Thromb Haemost; 2014 Sep; 12(9):1494-502. PubMed ID: 25040799
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.